Morgan Colby Wood - 13 Nov 2023 Form 4 Insider Report for PROCEPT BioRobotics Corp (PRCT)

Reporting relationship: Director
Issuer ticker: PRCT
Reported as of: 13 Nov 2023
Net transaction value: -$804,810
SEC form: 4
Accepted by SEC: 14 Nov 2023, 16:12:12 UTC
Prior SEC filing: 16 Jun 2023
Source filing: View source filing
Reporting owner signature: /s/ Jonathan Stone, Attorney-in-Fact for Morgan Colby Wood

Key filing fact

Morgan Colby Wood filed Form 4 for PROCEPT BioRobotics Corp (PRCT) on 14 Nov 2023.

Key facts

This page summarizes Morgan Colby Wood's Form 4 filing for PROCEPT BioRobotics Corp (PRCT).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 14 Nov 2023, 16:12.

Change

Previous filing in this sequence was filed on 16 Jun 2023.
Current net transaction value: -$804,810.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PRCT transaction

Common Stock

Sale

Transaction value: $804,810
Shares: -25,000
Change %: -18%
Price: $32.19
Shares after: 112,425
Date: 13 Nov 2023
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.1416 to $32.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.